Navigation Links
Healionics Corporation Announces Partnership to Develop and Distribute STARcuff(TM)
Date:9/20/2007

STARcuff designed to reduce catheter-related infections

REDMOND, Wash., Sept. 20 /PRNewswire/ -- Healionics Corporation, a provider of biomaterial solutions to enhance the biocompatibility and performance of current and next-generation medical devices, today announced a partnership deal with Strategic Applications Inc. (SAI), a leading manufacturer and supplier of specialty catheter and infusion devices. Healionics' deal with SAI will fully fund a catheter cuff study that will compare Healionics' STARcuff to other leading catheter cuffs currently available on the market. The deal also includes an Exclusive Supply and Distribution Option Agreement, which will give SAI the right to distribute STARcuff in specific global markets.

Additional terms of the deal include SAI's purchase of STARcuffs from Healionics for assembly on SAI catheters, and royalty payments to Healionics based on net sales. If STARcuff performs as expected, it has the potential to be the new standard for catheter cuffs.

"STARcuff is a very promising solution to reduce infections associated with long-term catheters," said Michel Alvarez, Chief Operating Officer of Healionics. "The STARcuff is designed to allow the patient's own tissue to grow into it and heal -- providing a natural skin seal or barrier to help prevent bacteria from entering the body along the outside of the catheter."

Hospital-acquired infections that kill people are often catheter-related infections derived from long-term catheter use. The Center for Disease Control estimates that 1.7 million hospital-acquired infections occur each year that result in nearly 100,000 deaths. There are 250,000 cases of Central Venous Catheter-related infections each year that result in approximately 60,000 deaths. Catheter-related infections are an enormous burden to the health care system and cost on the average of $25k to treat a patient per each occurrence. The long-term catheter market is approximately $500M per year in the US alone and is expected to grow at a rate of over 4% per year.

STARcuffs are just one of the many potential uses for STAR Material(TM). STAR Material was invented by Andrew Marshall Ph.D. and by Buddy D. Ratner Ph.D. at UWEB (University of Washington Engineered Biomaterials). Dr. Andrew Marshall recently joined the Healionics team as Lead Scientist.

About Healionics Corporation

Healionics is a privately held biomaterials company whose mission is to partner with medical device manufacturers to enhance the biocompatibility and performance of current and next-generation devices in order to dramatically reduce deaths that are related to biocompatibility issues. Healionics has licensed STAR Material -- Sphere Templated Angiogenic Regenerative Material -- that works with the body to promote healing and enables the biocompatibility of a wide range of medical devices that are implanted into the body. Healionics Corporation is headquartered in Redmond, Washington. For more information, please visit http://www.healionicscorp.com.


'/>"/>
SOURCE Healionics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Trouble-shooting: Misincorporation or low fidelity
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. Promega Corporation: Wisconsins quiet innovator
5. Giuliani will keynote RedPrairie Corporations user conference
6. Madison Development Corporation makes loans to three area companies
7. Corporations and blogging
8. Metavante acquires Florida banking corporation
9. TriMas Corporations Cequent Group Acquires Chem-Chrome, Inc.
10. Speaker announces business members of IT Task Force
11. Doyle announces technology tax credits for Berbee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... -- On Thursday, February 11, 2-1-1 San Diego ... and disaster services, and the Community Information Exchange ... coordination and service delivery for the community to better ... better connect service providers to the information they can ... has handled more than 2.5 million connections ...
(Date:2/4/2016)... - New FDA action date of July ... action date of July 22, 2016   --> ... 22, 2016   - Lifitegrast has the ... for the treatment of signs and symptoms of dry eye disease ... to be the only product approved in the U.S. in the past decade indicated for ...
(Date:2/4/2016)... 4, 2016 Beike Biotechnology, the ... attended a ceremony in late 2015 to mark their ... in 2016. --> --> ... for Personalized Cell Therapy" was hosted by the Shenzhen ... both subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a ... targeted antiviral therapies, announced today that it will present ... held February 8-9, 2016, at the Waldorf Astoria New ... Healthcare Conference, taking place in New York ... Sapirstein , Chief Executive Officer of ContraVir, will provide ...
Breaking Biology Technology:
(Date:2/2/2016)... 2, 2016   Parabon NanoLabs (Parabon) ... Army Research Office and the Defense Forensics and ... of the company,s Snapshot Kinship Inference ... more generally, defense-related DNA forensics.  Although Snapshot is ... appearance and ancestry from DNA evidence), it also ...
(Date:2/1/2016)... , Feb. 1, 2016  Today, the first ... (AHA) announced plans to develop a first of its ... power of IBM Watson. In the first application of ... IBM (NYSE: IBM ), and Welltok will create ... health assessments with cognitive analytics, delivered on Welltok,s health ...
(Date:1/27/2016)... Jan. 27, 2016  Rite Track, Inc. a leading ... West Chester, Ohio announced today the ... staff, based in Austin, Texas , ... to provide modifications, installations and technical support offerings for ... of PLUS, commented, "PLUS has provided world class service ...
Breaking Biology News(10 mins):